We back companies that share our vision for women's health
Nuttall Women’s Health invests in early to growth stage ventures developing devices, diagnostics and therapeutics that advance women’s health through innovative and rigorous science.
We believe that backing scientifically grounded companies will help accelerate and scale the innovative tools and solutions they are developing, so we can improve women’s healthcare outcomes sooner. All investment returns are reinvested into NWH research funding opportunities.
The companies we fund
We are most interested in working with companies that are aligned with our mission and can demonstrate early validation and translational potential, with a pathway from research to real-world clinical impact.
Additional criteria:
Your company is committed to rigorous data, biomarker-based approaches or mechanism-driven innovation.
Your product innovation leverages validated science or breakthrough biological insights to improve outcomes.
Your company is focused on developing diagnostic platforms, innovative therapeutics, digital health tools or precision interventions tailored to female biology.
Pitch deck that clearly explains your mission, product, market, business model, traction and funding ask.
Financial overview.
Company overview/one-pager that concisely summarizes your company, product and mission.
Team information, including brief bios or LinkedIn profiles of the founders and key team members. Scientific or clinical validation (if applicable), including publications, clinical trial data, regulatory milestones and IP/patents.
Primary contact information, including name, role and direct contact details.
Interested in research funding?
NWH funds innovative scientific research that will transform women’s health. If you are pursuing research that addresses critical gaps in female- and sex-specific biological knowledge, explore our current targeted research initiatives.
